ACRIVON THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.45 USD | -5.82% |
|
+5.37% | +51.42% |
| May. 14 | Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 30 | North American Morning Briefing : More Earnings -2- | DJ |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-07-09 | 2024-07-10 | 2024-07-11 | 2024-07-12 | |
|---|---|---|---|---|
| Last | 7.13 $ | 7.16 $ | 7.91 $ | 7.45 $ |
| Volume | 73 517 | 98 216 | 98 542 | 116 517 |
| Change | +0.71% | +0.42% | +10.47% | -5.82% |
| Opening | 7.06 | 7.17 | 7.32 | 7.93 |
| High | 7.22 | 7.70 | 7.95 | 8.00 |
| Low | 6.82 | 7.00 | 7.29 | 7.26 |
Performance
| 1 day | -5.82% | ||
| 1 week | +5.37% | ||
| Current month | +28.45% | ||
| 1 month | -3.50% | ||
| 3 months | -25.43% | ||
| 6 months | +55.53% | ||
| Current year | +51.42% | ||
| 1 year | -39.13% |
Volumes
marketsDaily volume
116 517
Estimated daily volume
116 517
Avg. Volume 20 sessions
131 301
Daily volume ratio
0.89
Avg. Volume 20 sessions USD
978 192.45
Record volume 1
38 277 212
Record volume 2
1 664 938
Record volume 3
1 050 285
Capital turnover ratio
0.00
Float rotation
0.01
Basic data
Capitalization (USD)
230 033 143
Net sales (USD)
0
Number of employees
60
Sales / Employee (USD)
0
Free-Float
59.72 %
Free-Float capitalization (USD)
137 374 372
Average Daily Capital Traded
0.43%
Highs and lows
1 week
6.81
8.00
1 month
5.508.00
Current year
3.1911.90
1 year
3.1913.50
3 years
3.1925.47
5 years
3.1925.47
10 years
3.1925.47
Indicators
Moving average 5 days
7.35
Moving average 20 days
6.66
Moving average 50 days
7.55
Moving average 100 days
7.17
Price spread / (MMA5)
-1.40%
Price spread / (MMA20)
-10.56%
Price spread / (MMA50)
+1.40%
Price spread / (MMA100)
-3.83%
STIM
RSI 9 days
76.44
RSI 14 days
64.42
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -5.82% | +5.37% | +51.42% | -39.13% | 230M | ||
| -1.13% | +2.63% | +22.10% | -4.09% | 46.55B | ||
| -0.50% | +3.15% | +46.45% | -2.48% | 41.84B | ||
| +2.16% | +7.72% | -3.12% | +2.07% | 40.84B | ||
| -0.20% | +3.78% | +36.10% | +27.78% | 32.95B | ||
| +1.61% | +1.61% | -6.30% | +21.03% | 28.27B | ||
| +0.55% | +4.76% | +18.71% | +34.96% | 27.78B | ||
| -0.77% | +2.17% | +46.15% | +39.85% | 14.26B | ||
| +1.84% | +10.09% | +44.52% | +84.26% | 13.69B | ||
| +1.23% | +8.22% | +0.19% | -8.44% | 12.18B | ||
| +2.52% | +8.28% | -8.55% | +3.36% | 11.14B | ||
| +2.60% | +2.63% | -5.79% | -11.27% | 9.36B | ||
| +4.13% | +20.28% | +57.39% | +70.15% | 7.45B | ||
| -0.01% | +5.44% | +27.69% | +99.32% | 7.38B | ||
| +0.17% | -2.56% | +34.54% | +16.44% | 7.33B | ||
| +1.46% | +4.14% | -5.12% | +12.52% | 7B | ||
| Average | +0.62% | +5.57% | +22.27% | +21.64% | ||
| Weighted average by Cap. | +0.62% | +4.86% | +20.62% | +17.12% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
01b59af652e905c9e5c5c2b3525100.nap-QoTCVOI9ApzwUZOautit9XYVTd9nuEEAQwOutr8.68ccL72NMKl7cKWGAcLK_oD0rEIkNOsM9w9BbjOam-ao6CEL67J5pAtu6w
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 7.45 | 10,580 | 94,909 |
| 03:59:57 pm | 7.42 | 100 | 84,329 |
| 03:59:57 pm | 7.42 | 100 | 84,229 |
| 03:59:50 pm | 7.43 | 100 | 84,129 |
| 03:59:50 pm | 7.43 | 100 | 84,029 |
| 03:59:50 pm | 7.43 | 100 | 83,929 |
| 03:59:50 pm | 7.43 | 200 | 83,829 |
| 03:59:50 pm | 7.435 | 100 | 83,629 |
| 03:59:50 pm | 7.45 | 100 | 83,529 |
| 03:59:42 pm | 7.43 | 100 | 83,429 |
Monthly variations
Annual change
| 2024 | +51.42% | ||
| 2023 | -57.29% | ||
| 2022 | -30.77% |
- Stock Market
- Equities
- ACRV Stock
- Quotes Acrivon Therapeutics, Inc.
